March

March 26, 2014

Tumorigenesis: cAMP response element-binding protein (CREB) suppresses the expression of tumor suppressor Foxo3a via up regulation of its target gene, 26/March/2014, 22.16

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Tumorigenesis: cAMP response element-binding protein (CREB) suppresses the expression of tumor suppressor Foxo3a via up […]
March 26, 2014

Insights into Betel-nut induced cancer cell migration, invasion and metastasis: Areca nut extract suppresses the expression of Hoxd10 via up regulation of its target gene, 26/March/2014, 22.11

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Insights into Betel-nut induced cancer cell migration, invasion and metastasis: Areca nut extract suppresses […]
March 26, 2014

Treating human cancer with a Diabetic pill: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppresses the expression of cancer stem cell/reprogramming protein Sox2 via up regulation of its target gene, 26/March/2014, 6.54 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Treating human cancer with a Diabetic pill: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes […]
March 25, 2014

Molecular cancer therapy: Fulvestrant, an estrogen receptor antagonist, increases the expression of tumor suppressor KRIT1/CCM1 via down regulation of its target gene, 26/March/2014, 5.07 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Molecular cancer therapy: Fulvestrant, an estrogen receptor antagonist, increases the expression of tumor suppressor KRIT1/CCM1 via down regulation of […]